InsightsSupply Chain & Operations

One factory made 60% of America's IV fluids.

By Uttam Dinodia1 min readView this post on LinkedIn

On 27 September 2024, Hurricane Helene flooded it.

Hospitals supplied from Baxter's North Cove plant were told to expect roughly 40% of normal volumes.

Elective surgeries were postponed. A routine bag of saline had stopped the most expensive work a hospital does.

The useful numbers are two others (David Simchi-Levi, William Schmidt and Yehua Wei, Harvard Business Review, 2014). One is time to recover, how long a site takes to restart. The other is time to survive, how long the chain can run without it.

The FDA declared the saline shortage over on 8 August 2025. Recovery was measured in months. Survival, for many hospitals, was measured in days.

Where recovery outlasts survival, the exposure is real whatever the spend.

For a public buyer of essential medicines:

  1. List the items where one site supplies most of the volume, whatever the unit price.
  2. Ask each supplier how long that site would take to restart after a flood or fire. Add half again: critics say suppliers tend to understate it.
  3. Where that answer is longer than your stock cover, split the award or hold more stock. Treat the higher price as the premium on the insurance.

Concentration can be looked up. Exposure has to be measured.

Which product in your range comes from a single site, and how many weeks could you run without it?

Uttam Dinodia

Uttam Dinodia

Pharmaceutical Business Consultant & Executive Director, A One Afro Limited

Over 22 years in pharmaceutical supply. Helps international manufacturers and Zambian institutions with public tenders, ZAMRA regulatory pathways and distribution.